Respiratory Flashcards

1
Q

Causes of upper zone predominant pulmonary fibrosis?

A

S - silicosis (massive fibrosis), sarcoidosis
C - coal workers pneumoconiosis
H - histiocytosis (pulmonary langerhans histiocytosis - “cystic”)
A - allergic bronchopulmonary aspergillosis
A - ankylosing spondylitis
R - radiation
T - tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of lower zone predominant pulmonary fibrosis?

A

D - dermatomyositis, polymyositis
R - rheumatoid arthritis
A - asbestosis
S - scleroderma
C - cryptogenic (ideopathic) pulmonary fibrosis
O - “other”; drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drugs that cause pulmonary fibrosis?
What pattern typically?

A

NSIP

CVS - Amiodarone, hydralazine
Chemo - MTX, Bleomycin
ABx - nitrofurantoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Features on HRCT of usual interstitial pneumonia (UIP)?

What major condition is this associated with?

A

Honeycombing
Traction bronchiectasis
Reticular opacities
Subpleural (peripheral) and basal predominance

Idiopathic pulmonary fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features on HRCT of non-specific interstitial pneumonia (NSIP)?

Name 5 causes

A

Ground glass opacities
Reticular opacities
Traction bronchiectasis
Diffuse changes - may have subpleural sparing

Idiopathic
Drug associated
Scleroderma
Hypersensitivity pneumonitis
HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Predominantly UIP or NSIP for below autoimmune conditions:
1. RA
2. Scleroderma
3. DM/PM
4. ANCA vasculitis
5. Sjogrens

A
  1. RA = UIP
  2. Scleroderma = NSIP
  3. DM/PM = NSIP
  4. Sjogrens = NSIP
  5. ANCA vasculitis = UIP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Features on radiograph of cryptogenic organizing pneumonia?

A

Bilateral patchy, diffuse ground glass opacities with normal lung volumes

Peripheral and lower lobe predominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Benefits of HFNP compared with NIV in T1 respiratory failure?

A

Reduces all cause mortality
Reduces HAP
Reduces need for ventilation
Improved patient comfort

Unclear impact on hospital and ICU stay/admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What FiO2 can nasal cannula deliver and at how many litres per minute?

A

1-6L/minute
FiO2 0.24-0.4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What FiO2 can a venturi mask deliver and at how many litres per minute?

A

2-15L/minute
FiO2 0.24 - 0.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What FiO2 can a non-rebreather mask deliver and at how many litres per minute?

A

10-15L/minute
FiO2 0.6-0.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What FiO2 can high flow nasal cannula deliver and at how many litres per minute?

A

15-60 litres/minute
FiO2 0.3 - 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drugs/toxins that are definitely associated with pulmonary arterial hypertension?

A

Appetite suppressants - fenfluramine, dexfenfluramine, aminorex

Toxins - rapeseed oil, methamphetamine

Dasatanib (TKI for CML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs/toxins that are possibly associated with pulmonary arterial hypertension?

A

Cocaine, amphetamines, Appetite suppressants - diethylproprion, Phentermine, Phenylopropanolamine
Leflunomide
IFN-alpha and IFN-beta
St. Johns wort
Bosutinib (TKI for CML)
Alkylating agents (i.e. cyclophosphamide)
Tryptophan
Direct acting agents against HCV
Chinese herb Qing Dai

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Scoring system components for mortality and hospital duration in empyema?

A

RAPID

R - renal function: elevated BUN (<5, 5-8, >8 = 0, +1 or +2)
A - age (<50, 50-70, >70 = 0, +1, or +2)
P - purulenet pleural fluid (NON-PURULENT is worse; (Yes = 0, No = +1)
I - infection source (Community = 0, Hospital-Acquired = 1)
D - Dietary/Serum Albumin (>27=0, <27=+1)

Interpretation
0-2 points = Low risk (1.5% 3/12 mortality) 3-4 points = medium (17.8% 3/12 mortality)
5-7 = High risk (47.8% 3/12 mortality)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications for step up therapy in Asthma

A

Nocturnal symptoms or on waking
Daytime symptoms and/or need for reliever >2
Any limitation of activity

“Well controlled asthma” is therefore the opposite:
- daytime symptoms/need for SABA (not before exercise) ≤ 2 days per week
- no limitation to activities
- no nocturnal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Features of low risk lung nodules

A

<8mm (<5mm = 1% maignant, 5-0 = 2-6% malignant)

Solid appearance

Smooth borders

Singular nodule

Non-upper lobe location

Non-enhancing

18
Q

When to reimage a 9mm solid pulmonary nodule

What if part-solid?

What if nodule 6mm?

A

PET/CT at 3 months

Part solid –> CT at 3-6 months

6mm solid –> CT at 6-12 months

19
Q

Flow volume loop with inspiratory plateau but normal expiration?
What about if expiratory loop was also flattened?

A

Flattened inspiratory plateua but normal expiration - variable extrathoracic obstruction (i.e. vocal cord paralysis)

Flattened inspiratory AND expiratory loop - fixed extrathoracic obstruction (i.e. tracheal stenosis)

20
Q

Flow volume loop with expiratory plateau but normal inspiration?

A

Flattened expiratory loop but normal inspiration - variable extra thoracic obstruction (i.e. tracheal malacia)

21
Q

Components of the ISARIC score for COVID deterioration

A

Age
Gender
Number of co-morbidities

Respiratory rate
Peripheral oxygen saturation on room air

Glasgow coma scale
Urea
CRP

22
Q

Which are the 3 interstitial lung diseases associated with smoking? Do they improve with cessation of smoking?

A

Desquamative interstitial pneumonia
Langerhans cell histiocytosis (upper lobe)
Respiratory bronchiolitis interstitial lung disease (upper lobe; centrilobular emphysema)

Mostly yes

23
Q

In what cancers do EGFR TKIs have a role?

A

Head, neck, lung, colorectal cancer

24
Q

What is the major difference between erlotinib and osimertinib?

A

Osimertinib = active against T790 resistance mutations
Erlotinib/other egfr TKIsare not

25
What is the most common cause of HAP?
Aerobic gram -ve bacilli
26
Normal level of bicarb compensation of resp acidosis
for every 10mmhg CO2 above 40, bicarb increases by 1
27
5 causes of increased DLCO 4 causes of deceased DLCO
Increased - polycythemia - pulmonary haemmorhage - asthma - high altitude - left to right shunts - obesity Decreased - smoking (false due to high CO) - ILD - anemia - COPD
28
Agents used for treatment of mesothelioma
Epithelioid: cisplatin + pemtrexed +/- bevacizumab Non-epithelioid: nivolumab + ipilimumab
29
Factors that reduce FRC Impact on pre-oxygenation and safe apnea?
Pregnancy Obesity Very young age Reduces efficacy and efficiency of pre-oxygenation therefore reduces safe apnoea time
30
Targets of Nintedanib Major effect?
Platelet derived growth factor, fibroblast derived growth factor, VEGF Reduces decline in FVC
31
Major paraneoplastic syndromes in small cell lung cancer
Lambert eaton HPOA Hypercalcemia SIADH ACTH excess
32
Major paraneoplastic syndromes in squamous cell lung cancer
Hyperthyroidism (ectopic TSH) HPOA Hypercalcemia (PTH mediated) Clubbing
33
Equation for PAO2
PAO2 = FiO2 x (Patm - H20) - (PaCO2/R) Normal values: FiO2 0.21, Patm 760, H20 47, resp quotient 0.8 PAO2 = 0.21 x (760 - 47) - (PaCO2/0.8)
34
Antigen clusters associated with small cell lung cancers
Neuron specific enolase Dopa decarboxylase Calcitonin chromogranin A CD 56 or neural cell adhesion molecule (NCAM) Gastrin releasing peptide Insulin like growth factor 1
35
Effect of smoking on lung function tests Effect of caffeine
Smoking = decreased DLCO Caffeine = bronchodilation (increased FEV1)
36
Favourable prognosis of Lung Cancer?
Carcinoid
37
IV to Oral Converstion - tramadol, oxycodone, morphine, hydromophone
T1O2M3H5
38
Conversion Ratio: Morphine to codeine Morphine to hydromoprhone Morphine to oxycdone Morphine to tapentadol Morphine to tramadol
Codeine: 1:10 tapentadol 1:3 tramadol 1:5 oxycodone: 1.5:1 hydromorphone 5:1
39
indications to drain pleural space parapneumonic effsuion
pH <7.2, large free flowing pleural effusion more then 50% of hemithorax, positive culture, positive gram stain.
40
ILD associated with Sjogren's Disease?
Lymphocytic interstitial pneumonitis
41
Mab and Target for Asthma Omalizumab Dupilumab Reslizumab Mepolizumab
Omalizumab - targets IgE Dupilumab IL 13 _ IL 4 Reslizumab IL 5 Mepolizumab IL 5 Itepekimab - IL - 33 Tezepilumab targetd TSLP
42
Groups of PAH Tx
1) Idiopathic/familial/HIV/ Connectiv tissue Tx underlying considtion + transplant 2) Left Heart Disease - optimise HF therapy 3) Due to Resp Disease (COPD, ILD etc) - oxygen 4) chronic thromboemoblic - warfarin 5) Unclear/multifactorial - heam disorders, systemic disorders aka sarcoid scleraderma. - Treat underlying condition if possible General Tx: 1) low prostacyclin - give prostacyclin eg Epoprostenol 2) Low nitric oxide - treat with phosphodisesterse type 5 inhbitor (sildenafil) 3) High endothelin 1 - Treat with endothelin recptor antagonist (Bosentan) 4) If positive vasoreactive test - Ca-blocker trial - nifedipine.